US2006148659A1PendingUtilityA1
Fracturing fluids containing borate esters as crosslinking agents
Est. expiryJun 25, 2022(expired)· nominal 20-yr term from priority
C09K 8/685
43
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A formation treating fluid comprises one or more borate esters, a liquid carrier and, one or more cross linkable polymer wherein the formation treating fluid has an alkaline pH when the formation treating fluid is positioned in a formation. The formation treating fluid is useful in high temperature operations such as hydraulic fracturing.
Claims
exact text as granted — not AI-modified1 . A formation treating fluid including a cross linkable polymer and comprises, prior to the cross linkable polymer being cross linked:
a) a borate ester comprising a triester or a cyclic ester; b) an organic solvent for the borate ester; c) a liquid carrier; and, d) the cross linkable polymer wherein the formation treating fluid has an alkaline pH when the formation treating fluid is positioned in a formation.
2 . The formation treating fluid as claimed in claim 1 further comprising a proppant.
3 . The formation treating fluid as claimed in claim 1 further comprising a pH adjustment agent to raise the pH of the formation treating fluid to about 8 or higher.
4 . The formation treating fluid as claimed in claim 3 wherein the pH is sufficiently low to prevent significant hydrolysis of the cross linkable polymer.
5 . The formation treating fluid as claimed in claim 4 wherein the pH adjustment agent is an alkali or alkaline salt.
6 . The formation treating fluid as claimed in claim 5 wherein the alkali or alkaline salt is one or more of an hydroxide, a carbonate, a bicarbonate and a silicate.
7 . The formation treating fluid as claimed in claim 1 wherein the formation treating fluid has a pH from about 8 to about 13.
8 . The formation treating fluid as claimed in claim 1 wherein the formation treating fluid has a pH from about 9.5 to about 11.5.
9 . The formation treating fluid as claimed in claim 1 wherein the organic solvent is a cyclic organic compound.
10 . The formation treating fluid as claimed in claim 1 wherein the borate ester comprises from about 0.001 to about 1 vol. % of the formation treating fluid.
11 . The formation treating fluid as claimed in claim 1 wherein the borate ester comprises from about 0.005 to about 0.5 vol. % of the formation treating fluid.
12 . The formation treating fluid as claimed in claim 1 wherein the borate ester comprises from about 0.01 to about 0.1 vol. % of the formation treating fluid.
13 . The formation treating fluid as claimed in claim 1 wherein the liquid carrier comprises water, methanol or a mixture thereof.
14 . A formation treating fluid including a cross linkable polymer and comprises at the point of addition:
a) a borate ester in a cyclic organic solvent; b) a liquid carrier; and, c) the cross linkable polymer wherein the formation treating fluid has an alkaline pH when the formation treating fluid is positioned in a formation.
15 . The formation treating fluid as claimed in claim 14 further comprising a proppant.
16 . The formation treating fluid as claimed in claim 14 further comprising a pH adjustment agent to raise the pH of the formation treating fluid to about 8 or higher.
17 . The formation treating fluid as claimed in claim 16 wherein the pH is sufficiently low to prevent significant hydrolysis of the cross linkable polymer.
18 . The formation treating fluid as claimed in claim 17 wherein the pH adjustment agent is an alkali or alkaline salt.
19 . The formation treating fluid as claimed in claim 18 wherein the alkali or alkaline salt is one or more of an hydroxide, a carbonate, a bicarbonate and a silicate.
20 . The formation treating fluid as claimed in claim 14 wherein the formation treating fluid has a pH from about 8 to about 13.
21 . The formation treating fluid as claimed in claim 14 wherein the formation treating fluid has a pH from about 9.5 to about 11.5.
22 . The formation treating fluid as claimed in claim 14 wherein the borate ester is one or more of a triester and a cyclic ester.
23 . The formation treating fluid as claimed in claim 14 wherein the borate ester comprises from about 0.001 to about 1 vol. % of the formation treating fluid.
24 . The formation treating fluid as claimed in claim 14 wherein the borate ester comprises from about 0.005 to about 0.5 vol. % of the formation treating fluid.
25 . The formation treating fluid as claimed in claim 14 wherein the borate ester comprises from about 0.01 to about 0.1 vol. % of the formation treating fluid.
26 . The formation treating fluid as claimed in claim 14 wherein the liquid carrier comprises water, methanol or a mixture thereof.Join the waitlist — get patent alerts
Track US2006148659A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.